Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GGSH Participações is a Brazilian healthcare holding company that operated Ghelfond Diagnósticos, a prominent provider of diagnostic imaging and clinical laboratory services. Based in São Paulo, the company managed a network of specialized units offering a wide range of exams, including magnetic resonance imaging, computed tomography, and ultrasound. In 2021, GGSH Participações was acquired by Dasa, the largest diagnostic medicine company in Latin America, to strengthen Dasa's presence in the São Paulo metropolitan market. The company is recognized for its long-standing history in the Brazilian private healthcare sector and its focus on high-complexity diagnostic services. Following the acquisition, its operations were integrated into Dasa's extensive healthcare ecosystem, which includes hospitals and diagnostic centers across Brazil.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GGSH Participações.